Skip to main content
. 2020 Aug 25;2020:3268047. doi: 10.1155/2020/3268047

Figure 1.

Figure 1

Inhibitory effects of Yiqi Xingnao (YQXN) oral liquid on neurological deficits and infarct volume after ischemia/reperfusion (I/R). (a) The neurological deficit scores. (b) 2,3,5-Triphenyltetrazolium chloride (TTC) staining (white) indicating infarct sizes in rats with different treatments. (c) Percent of infarct volume based on the TTC staining results. P < 0.05, compared with the sham-operated group; #P < 0.05, compared with the I/R group.